What is the long-term trend for Celanese Corporation's other — research and development expense?

Over 3 years (2022 to 2025), Celanese Corporation's other — research and development expense has grown at a -100.0% compound annual growth rate (CAGR), from $1M to $0.

What does other — research and development expense mean?

Includes costs incurred by the 'Other' segment to develop new products, improve existing technologies, or explore innovative processes. This investment reflects the company's commitment to long-term growth and competitive differentiation within this specific business area. High levels of R&D spending indicate a focus on future innovation and market expansion.

Celanese Corporation (CE) Other — Research and Development Expense

Screener

Other segment segments

Engineered Materials

$19M-5.0%

Acetyl Chain

$9M-18.2%

Similar metrics at other companies

KEYSCSG — Research and Development Expense

$226M+29.1%

KEYSEISG — Research and Development Expense

$77M+22.2%

MOG.AIndustrial — Research and Development Expense

$8.77M-2.0%

CMIAccelera — Research and Development Expense

$32M-25.6%

CMIComponents — Research and Development Expense

$81M+8.0%

CMIEngine — Research and Development Expense

$164M+5.8%

Other financials

Income statement

See full

Revenue$2.8B+8.7%

Gross profit$618.0M+15.7%

Operating income$276.0M+19.5%

Net income$125.0M-36.5%

EPS (diluted)$1.13-37.2%

Balance sheet

See full

Cash & equivalents$1.4B+16.3%

Total debt$13.7B+1.9%

Total equity$4.2B-20.7%

Total assets$21.4B-9.7%

Cash flow

See full

Operating cash flow$209.0M-49.0%

CapEx$62.0M-33.3%

Free cash flow$147.0M-53.6%

Valuation

See full

Market cap$4.82B-7.8%

Enterprise value$17.2B-2.0%

P/S0.5×0.0×

Profitability

See full

Gross margin20.9%-0.8pp

Operating margin-23.7%-32.7pp

Net margin-12.2%-2.5pp

FCF margin7.3%+0.8pp

Returns & leverage

See full

Return on equity-25.2%-1.1pp

Debt / equity3.3×+0.7×

Current ratio1.4×-0.6×

Where this comes from

Reported directly by Celanese Corporation in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The source filing: Celanese Corporation’s 10-Q, filed August 5, 2026.

Filed: Aug 5, 2026, 4:22 PM EDT
Fiscal quarter: Q2 FY2026
Calendar quarter: Q2 2026
Accession: 0001306830-26-000117

Line item	Engineered Materials / (In $ millions) / Three Months Ended June 30, 2026	Acetyl Chain / (In $ millions) / Three Months Ended June 30, 2026	Other Activities / (In $ millions) / Three Months Ended June 30, 2026	Eliminations / (In $ millions) / Three Months Ended June 30, 2026	Consolidated
Gross profit	317	297	4	—	618
Selling, general and administrative expenses	(94)	(30)	(127)	—	(251)
Amortization of intangible assets	(39)	—	—	—	(39)
Research and development expenses	(19)	(9)	(1)	—	(29)
Other (charges) gains, net (Note 18)	(8)	(21)	(2)	—	(31)
Gain (loss) on disposition of business and assets, net	(1)	—	(1)	—	(2)
Other segment items(2)	—	—	10	—	10
Operating profit (loss)	156	237	(117)	—	276

Item 1. Financial Statements

FAQ

What is Celanese Corporation's other — research and development expense?: Celanese Corporation (CE) reported other — research and development expense of $1M in Q2 2026.
What is the long-term trend for Celanese Corporation's other — research and development expense?: Over 3 years (2022 to 2025), Celanese Corporation's other — research and development expense has grown at a -100.0% compound annual growth rate (CAGR), from $1M to $0.
What does other — research and development expense mean?: Includes costs incurred by the 'Other' segment to develop new products, improve existing technologies, or explore innovative processes. This investment reflects the company's commitment to long-term growth and competitive differentiation within this specific business area. High levels of R&D spending indicate a focus on future innovation and market expansion.